Latest AI and machine learning research in cardiovascular for healthcare professionals.
Multiphase CT studies are routinely obtained in clinical practice for diagnosis and management of various diseases, such as cancer. However, the CT studies can be acquired with low radiation doses, different scanners, and are frequently affected by motion and metal artifacts. Prior approaches have targeted the quality improvement of one specific CT phase (e.g., non-contrast CT). In this work, we...
The generation of synthetic CT (sCT) images from cone-beam CT (CBCT) data using deep learning methodologies represents a significant advancement in radiation oncology. This systematic review, following PRISMA guidelines and using the PICO model, comprehensively evaluates the literature from 2014 to 2024 on the generation of sCT images for radiation therapy planning in oncology. A total of 35 rel...
Measurement quality assurance (QA) practices play a key role in the safe use of Intensity Modulated Radiation Therapies (IMRT) for cancer treatment....
The ErbB receptor family, including EGFR and HER2, plays a crucial role in cell growth and survival and is associated with the progression of variou...
Objective: There exist several X-ray computed tomography (CT) scanning strategies to reduce a radiation dose, such as (1) sparse-view CT, (2) low-do...
Survival prediction is a crucial task in the medical field and is essential for optimizing treatment options and resource allocation. However, curre...
This study explores how causal inference models, specifically the Linear Non-Gaussian Acyclic Model (LiNGAM), can extract causal relationships betwe...
Lung cancer patients often experience increased metastasis formation after radiotherapy. However, it is incompletely understood whether radiation affe...
The tumor microenvironment (TME) is a complex ecosystem of diverse cell types whose interactions govern tumor growth and clinical outcome. While multi...
Cancer of unknown primary (CUP) remains a major diagnostic hurdle, compromising therapies that depend on accurately identifying tissue of origin. We p...
The metabolic heterogeneity of breast cancer represents a significant challenge for the identification of biomarkers and therapeutic targets. To addre...
Patient-derived organoids (PDOs) are emerging as advanced 3D ex vivo novel alternative method (NAM) preclinical models, offering significant advantage...
While gene sequencing is routine in cancer care, translating sequences into treatment decisions remains a challenge. Here we introduce MutationProject...
Breast cancer (BRCA) is a leading cause of cancer-related mortality in women, characterized by marked heterogeneity in molecular subtypes, immune micr...
Identification of mitotic cells and its down-stream analysis, is an important parameter in understanding the pathology of cancer, predicting response ...
Transformer-based single-cell foundation models often rely on ranked-gene (RG) sequences where genes, ranked by expression, are often not functionally...
Accurate RNA splicing is essential for gene expression and protein function, yet the mechanisms governing splice site recognition remain incompletely ...
Chemoresistance and epithelial-mesenchymal transition (EMT) are associated with failure of cancer chemotherapy and poor survival of patients. We have ...
Artificial intelligence (AI) is making notable advances in digital pathology but faces challenges in human interpretability. Here we introduce EXPAND ...
Advancements in transmission electron microscopy (TEM) have enabled in-depth studies of biological specimens, offering new avenues to large-scale imag...